![Sheila Gujrathi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheila Gujrathi
Direktor/Vorstandsmitglied bei
PROCESSA PHARMACEUTICALS, INC.
Vermögen: 4 Mio $ am 31.08.2026
Profil
Sheila Gujrathi ist eine Unternehmerin, die Gossamer Bio, Inc. gegründet hat und 5 verschiedene Unternehmen geleitet hat. Dr. Gujrathi ist Vorstandsvorsitzende von Turning Point Therapeutics, Inc. und Vorstandsvorsitzende von ADARx Pharmaceuticals, Inc. sowie Vorstandsvorsitzende von GB001, Inc. und GB006, Inc. Sheila Gujrathi ist auch im Vorstand von Janux Therapeutics, Inc. In der Vergangenheit war sie President, Chief Executive Officer & Director bei Gossamer Bio, Inc. und Vice President-Global Clinical Development Group bei Bristol Myers Squibb Co. sowie Chief Medical Officer bei Receptos LLC (einer Tochtergesellschaft von Bristol Myers Squibb Co.) und Franchise Team Leader bei Genentech, Inc. Sie hat an der Northwestern University promoviert und einen Undergraduate-Abschluss erworben.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
JANUX THERAPEUTICS, INC. 0,19 % | 15.02.2026 | 112.639 ( 0,19 % ) | 2 Mio $ | 31.08.2026 |
| 06.08.2026 | 90.160 ( 0,29 % ) | 2 Mio $ | 31.08.2026 | |
49,61 % | 28.07.2026 | 70.812 ( 49,61 % ) | 145 165 $ | 31.08.2026 |
Aktive Positionen von Sheila Gujrathi
| Unternehmen | Position | Beginn |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 18.03.2021 |
| PROCESSA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 28.07.2026 |
| BLOSSOMHILL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2026 |
Generian Pharmaceuticals, Inc.
 Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Vorsitzender | 01.05.2023 |
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Berater | - |
GB006, Inc.
 GB006, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Vorstandsvorsitzender | - |
GB001, Inc.
 GB001, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Sheila Gujrathi
| Unternehmen | Position | Ende |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Vorsitzender | 04.03.2026 |
| ADARX PHARMACEUTICALS, INC. | Vorsitzender | 01.01.2025 |
| ░░░░░░░ ░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Sheila Gujrathi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
20
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 20 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Receptos LLC
 Receptos LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapeutics in immune disease | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity invests in companies located across the globe primarily in North America, Asia, Europe and Israel. The firm focuses on biopharmaceuticals, medical technology and healthcare services. It participates in seed-stage, early stage, growth transactions. It also provides debt capital and monetize royalty streams and invests in publicly-traded companies. | Finance |
Feinberg School of Medicine
 Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming Venture Partners invests in companies located in the United States and Europe. The firm focuses on the healthcare sector. It participates in early stage capital transactions. | Finance |
GB001, Inc.
GB001, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
GB006, Inc.
GB006, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Generian Pharmaceuticals, Inc.
Generian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops gain-of-function drugs that activate key cellular networks | Health Technology |
ADARx Pharmaceuticals, Inc.
 ADARx Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage pipeline that develops RNA medicines for diseases | Commercial Services |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
Immpact Bio USA, Inc.
 Immpact Bio USA, Inc. BiotechnologyHealth Technology Develops cell therapy for treating cancer | Health Technology |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
